Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.While many investors like to look for moment ...

GoodRx Holdings, Inc. (GDRX) reported $196.64 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 6.8%. EPS of $0.08 for the same period compares to $0.07 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $195.59 million, representing a surprise of +0.54%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.08.While investors closely watch year-over-year changes in headline numbers -- revenue and earning ...

Shares of GoodRx Holdings (GDRX 20.40%) rallied by 20.4% on Thursday after the company announced stronger-than-expected quarterly results and a new stock buyback program.A solid quarterIn the fourth quarter, GoodRx's revenue grew 7% year over year to $196.6 million, translating to adjusted (non-GAAP) net income of $31.1 million, or $0.08 per share, up from $0.07 per share in the prior-year period. Analysts, on average, were only modeling for earnings of $0.07 per share on slightly lower revenue. GoodRx ende ...

GoodRx Holdings, Inc. (NASDAQ:GDRX) Q4 2023 Earnings Conference Call February 29, 2024 8:00 AM ET Company Participants Whitney Notaro - VP, IR Scott Wagner - Interim CEO Karsten Voermann - CFO Conference Call Participants Stephanie Davis - Barclays Lisa Gill - JPMorgan Charles Rhyee - TD Cowen Michael Cherny - Leerink Jailendra Singh - Truist Jian Li - Evercore ISI Allen Lutz - Bank of America Daniel Grosslight - Citi Craig Hettenbach - Morgan Stanley Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Farg ...

GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.07 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post earnings of $0.06 per share when it actually produced earnings of $0.06, delivering no surprise.Over the last four quarters, the company has surpassed consensus EPS estimates two times.GoodRx Holdings, Inc., which belon ...

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., has released its financial results for the fourth quarter and full year 2023, which are consistent with its preliminary results announced on January 10, 2024. Fourth Quarter 2023 Highlights Revenue1 and Adjusted Revenue1,2 of $196.6 million Net loss of $25.9 million; Net loss margin of 13.2% Adjusted Net Income2 of $31.1 million; Adju ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-K __________________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Commission File Number: 001-39549 __________________________________________________ GoodRx Holdings, Inc. (Exact Name of Registrant as Specified in Its Charter) ______ ...

GoodRx Holdings, Inc. (GDRX) is expected to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended December 2023. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on February 29, 2024, might help the stock move higher if these key nu ...

GoodRx Holdings, Inc. (GDRX) closed the last trading session at $6, gaining 11.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $7.67 indicates a 27.8% upside potential.The average comprises 15 short-term price targets ranging from a low of $4.50 to a high of $12, with a standard deviation of $2.17. While the lowest estimate indicates a decline of 25% from the current price level ...

During flu season, you want to be on top of your strategy on how to quickly get better if you’re sick.Each month, PYMNTS tracks the most popular mobile apps in the prescription space for the Provider Ranking of Prescription Apps. By observing app use metrics, we score applications to determine the top players.For the sixth consecutive month, GoodRx leads the pack. CVS Caremark, CenterWell Pharmacy and Nimble Rx show the most upward score variation, each gaining three points. Publix Pharmacy loses the most g ...